Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? (Q53517010)
scientific article published in August 2000
Language:
Current Data About Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?
(P31) (Q13442814)
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

(P304) 281-285
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

(P407) (Q1860)

(P433) 2 Pt 1
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

(P478) 43
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

(P577) Tuesday, August 1, 2000
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

(P921) (Q181600)

(P1433) (Q15757046)
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

(P1476) "Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?" (language: en)
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

(P2093) Krueger GG
(P1545) 1
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Feldman SR
(P1545) 2
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Camisa C
(P1545) 3
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Duvic M
(P1545) 4
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Elder JT
(P1545) 5
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Gottlieb AB
(P1545) 6
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Koo J
(P1545) 7
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Krueger JG
(P1545) 8
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Lebwohl M
(P1545) 9
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Lowe N
(P1545) 10
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Menter A
(P1545) 11
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Morison WL
(P1545) 12
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Prystowsky JH
(P1545) 13
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Shupack JL
(P1545) 14
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Taylor JR
(P1545) 15
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Weinstein GD
(P1545) 16
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Barton TL
(P1545) 17
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Rolstad T
(P1545) 18
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

Day RM
(P1545) 19
(P248)
(P698) 10906652
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10906652

other details
description scientific article published in August 2000

External Links
(P356) 10.1067/MJD.2000.106374
(P698) 10906652
(P5875) 12412098